Prevalence of HIV, herpes simplex virus-2, and syphilis in male sex partners of pregnant women in Peru

Clark, Jesse L.; Konda, Kelika A.; Munayco, Cesar V.; Pún, Monica; Lescano, Andres G.; Leon, Segundo R.; Pajuelo, Jose; Suarez-Ognio, Luis; Klausner, Jeffrey D.; Coates, Thomas J.; Cáceres, Carlos F.
January 2008
BMC Public Health;2008, Vol. 8 Issue 1, p65
Academic Journal
Background: Sexually active heterosexual men may represent an important risk factor for HIV infection and STI transmission to their female partners and unborn children, though little is known about the prevalence of STIs in this population. We sought to determine the prevalence of HIV, herpes simplex virus type 2 (HSV-2), and syphilis infection and associated risk behaviors among male sex partners of pregnant women in Peru. Methods: Survey and seroprevalence data were collected from 1,835 male partners of pregnant women in four cities in Peru. Serum was tested for antibodies to HIV, HSV-2, and syphilis. Results: Among the 1,835 male participants, HIV prevalence was 0.8% (95% CI = 0.5-1.4%), HSV-2 16.0% (95% CI = 14.3-17.8%), and syphilis 1.6% (95% CI = 1.0-2.2%). Additionally, 11.0% reported a lifetime history of intercourse with men, and 37.1% with female sex workers. Unprotected intercourse with men during the previous year was reported by 0.9% and with female sex workers by 1.2%. Conclusion: Pregnant women's sex partners reported lifetime sexual contact with core risk groups, had an elevated prevalence of HSV-2, and demonstrated the potential to spread HIV and other STIs to their partners. Though the prevalence of HIV in the population was not significantly higher than observed in other samples of heterosexuals in Peru, the risk of HIV transmission to their female partners may be exacerbated by their increased prevalence of HSV-2 infection. Further study of heterosexual populations is necessary to fully understand the epidemiology of HIV/STIs in Latin America.


Related Articles

  • Herpes Simplex Virus Type 2, Genital Ulcers and HIV-1 Disease Progression in Postpartum Women. Roxby, Alison C.; Drake, Alison L.; John-Stewart, Grace; Brown, Elizabeth R.; Matemo, Daniel; Otieno, Phelgona A.; Farquhar, Carey // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Background: Co-infection with herpes simplex virus type 2 (HSV-2) has been associated with increased HIV-1 RNA levels and immune activation, two predictors of HIV-1 progression. The impact of HSV-2 on clinical outcomes among HIV-1 infected pregnant women is unclear. Methods: HIV-1 infected...

  • MANAGEMENT OF GENITAL HERPES INFECTIONS IN HIV INFECTED PATIENTS. Samraj, S; Patel, R // Indian Journal of Dermatology;2006, Vol. 51 Issue 1, p8 

    The article provides information on the management of genital herpes infections in HIV-infected patients. The mechanism of action of antiviral drugs used to treat herpes infections is discussed. There are several antiviral methods for the determination of susceptibility in herpes simplex virus....

  • Herpes simplex virus type 2: epidemiology and management options in developing countries. Paz-Bailey, G.; Ramaswamy, M.; Hawkes, S. J.; Geretti, A. M. // Postgraduate Medical Journal;Jun2008, Vol. 84 Issue 992, p299 

    Genital herpes simplex virus type 2 (HSV2) is highly prevalent worldwide and an increasingly important cause of genital ulcer disease (GUD). Continued HSV2 transmission is facilitated by the large number of undiagnosed cases, the frequency of atypical disease and the occurrence of asymptomatic...

  • Herpes Simplex Virus Type 2 Infection Does Not Influence Viral Dynamics during Early HIV-1 Infection. Cachay, Edward R.; Frost, Simon D. W.; Richman, Douglas D.; Smith, Davey M.; Little, Susan J. // Journal of Infectious Diseases;5/1/2007, Vol. 195 Issue 9, p1270 

    Objective. We sought to compare baseline and longitudinal plasma HIV-1 loads between herpes simplex virus type 2 (HSV-2)—seropositive and —seronegative individuals who are enrolled in a primary HIV-1 infection cohort in San Diego, California. Design. The study was a retrospective...

  • CORRESPONDENCE. Thackray, Alana M.; Field, Hugh J.; LeBlanc, Rona A.; Straus, Stephen E.; Papadopulos-Eleopulos, Eleni; Turner, Valendar F.; Papadimitriou, John M.; Alfonso, Helman; Page, Barry; Causer, David; Zaunders, John J.; Cunningham, Philip H.; Kaufmann, Gilbert R.; Cooper, David A. // Journal of Infectious Diseases;4/1/2000, Vol. 181 Issue 4 

    Presents several evidences on herpes simplex virus type 1 (HSV 1) and immunodeficiency virus type 1 (HIV 1) infections. Effects of famciclovir and valacyclovir on HSV1 infection; Differential benefits of famciclovir; Phenotypic profiles of CD4 and CD8 lymphocytes.

  • How Does Herpes Simplex Virus Type 2 Influence Human Immunodeficiency Virus Infection and Pathogenesis? Wald, Anna; Corey, Lawrence // Journal of Infectious Diseases;5/15/2003, Vol. 187 Issue 10, p1509 

    Editorial. Discusses a prospective cohort study of patients at sexually transmitted infection (STI) clinics in Pune, India. Evidence that antecedent herpes simplex virus type 2 (HSV-2) infection increases the rate of HIV type-1 infection; Relationship between genital ulcers and HIV-1; Factors...

  • Herpes Simplex Virus (HSV)-Suppressive Therapy Decreases Plasma and Genital HIV-1 Levels in HSV-2/HIV-1 Coinfected Women: A Randomized, Placebo-Controlled, Cross-Over Trial. Baeten, Jared M.; Strick, Lara B.; Lucchetti, Aldo; Whittington, William L. H.; Sanchez, Jorge; Coombs, Robert W.; Magaret, Amalia; Wald, Anna; Corey, Lawrence; Celum, Connie // Journal of Infectious Diseases;12/15/2008, Vol. 198 Issue 12, p1804 

    A randomized cross-over trial of herpes simplex virus type 2 (HSV-2)-suppressive therapy (valacyclovir, 500 mg twice daily, or placebo for 8 weeks, a 2-week washout period, then the alternative therapy for 8 weeks) was conducted among 20 Peruvianwomencoinfected with HSV-2...

  • Adherence in HIV Type 1 Prevention Trials. Baeten, Jared M. // Journal of Infectious Diseases;5/1/2010, Vol. 201 Issue 9, p1279 

    The article offers information on the results of the study on the prevention trials on the adherence of HIV Type 1. It mentions that herpes simplex virus type 2 (HSV-2) is the main cause of genital herpes that infects the majority of human immunodeficiency virus type 1 (HIV-1)-infected person...

  • Troubled by Cold Sores? Brown, Edwin W. // Medical Update;Mar99, Vol. 22 Issue 9, p1 

    Provides information on fever blisters or cold sores caused by the virus herpers simplex type 1. Treatment for cold sores; Difference of cold sores from canker sores; Approval of the drug Aphthasol.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics